Cochrane Abstracts
Subsidising artemisinin‐based combination therapy in the private retail sector
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Subsidising Artemisinin‐based Combination Therapy in the Private Retail Sector." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433997/all/Subsidising_artemisinin‐based_combination_therapy_in_the_private_retail_sector.
Subsidising artemisinin‐based combination therapy in the private retail sector. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433997/all/Subsidising_artemisinin‐based_combination_therapy_in_the_private_retail_sector. Accessed February 10, 2025.
Subsidising artemisinin‐based combination therapy in the private retail sector. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433997/all/Subsidising_artemisinin‐based_combination_therapy_in_the_private_retail_sector
Subsidising Artemisinin‐based Combination Therapy in the Private Retail Sector [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433997/all/Subsidising_artemisinin‐based_combination_therapy_in_the_private_retail_sector.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Subsidising artemisinin‐based combination therapy in the private retail sector
ID - 433997
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433997/all/Subsidising_artemisinin‐based_combination_therapy_in_the_private_retail_sector
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
